Collagen Stimulators and Their Use in the Treatment of Skin
AssigneeAvon Products, Inc.
InventorsUma Santhanam, Permanan Raaj Khusial
Life of this patent
Estimating the term…
Abstract
Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ cosmetic composition comprising novel active agents that enhance collagen production in the skin.
Claims19
A method for improving the aesthetic appearance of human skin comprising topically applying to an area of the skin in need thereof a composition according to Formula I(a):
- wherein,
- Q represents a 3-6 membered heterocyclic ring, wherein L1 and L2 are independently selected from a bond or a group ε1-(L3)l-ε2, where “l” is an integer from 0 to 4;
- where L3 is selected from —CH2—, —CHR*—, —C(R*)2—, —CH—, —CR*—, or a bond;
- and ε1 and ε2 are independently selected from —N—, —NH—, —NRN—, —O—, —S—, —(C═O)—, or a bond;
- Y is selected from —CH—, —CR*—, —CHR*—, —C(R*)2—, —N—, —O—, —S—, —NRN—, or a bond (i.e. absent);
- Z1 represents a bond, —CH2—, or —(C═O)—;
- Z2 represents a bond, —O—, NH—, —NRN—, —CH2—, —CHR*—, —C(R*)2—, —(CH2)p—, —(CH2)p—NH, or —(CH2)p—NRN—, where p is an integer from 1-6;
- X1 represents —CH2—, —CHR*—, —C(R*)2—, —NH—, —NRN—, —O—, or —S—;
- X2 and X3 represents nitrogen, —CH—, or —CR*—;
- R1-R5 are independently selected, at each occurrence, from a group R;
- wherein R is selected from hydrogen, —F;
- —Cl;
- —Br;
- —I;
- —OH, —OR*;
- —NH2;
- —NHR*;
- —N(R*)2;
- —N(R*)3+;
- —N(R*)—OH;
- —N(→O)(R*)2;
- —O—N(R*)2;
- —N(R*)—O—R*;
- —N(R*)—N(R*)2;
- —C═N—R*;
- —N═C(R*)2;
- —C═N—N(R*)2;
- —C(═NR*)—N(R*)2;
- —SH;
- —SR*;
- —CN;
- —NC;
- —(C═O)—R*;
- —CHO;
- —CO2H;
- —CO2−;
- —CO2R*;
- —(C═O)—S—R*;
- —O—(C═O)—H;
- —O—(C═O)—R*;
- —S—(C═O)—R*;
- —(C═O)—NH2;
- —(C═O)—N(R*)2;
- —(C═O)—NHNH2;
- —O—(C═O)—NHNH2;
- —(C═S)—NH2;
- —(C═S)—N(R*)2;
- —N(R*)—CHO;
- —N(R*)—(C═O)—R*;
- —(C═NR)—O—R*;
- —O—(C═NR*)—R*, —SCN;
- —NCS;
- —NSO;
- —SSR*;
- —N(R*)—C(═O)—N(R*)2;
- —N(R*)—C(═S)—N(R*)2;
- —SO2—R*;
- —O—S(═O)2—R*;
- —S(═O)2—OR*;
- —N(R*)—SO2—R*;
- —SO2—N(R*)2;
- —O—SO3−;
- —O—S(═O)2—OR*;
- —O—S(═O)—OR*;
- —O—S(═O)—R*;
- —S(═O)—OR*;
- —S(═O)—R*;
- —NO;
- —NO2;
- —NO3;
- —O—NO;
- —O—NO2;
- —N3;
- —N2—R*;
- —N(C2H4);
- —Si(R*)3;
- —CF3;
- —O—CF3;
- —PR*2;
- —O—P(═O)(OR*)2;
- —P(═O)(OR*)2;
- perfluoroalkyl;
- an aliphatic C1-C12 hydrocarbon radical;
- a C1-C12 aromatic hydrocarbon radical;
- or a C1-C12 heteroaryl radical;
- where R* is independently at each occurrence hydrogen or a straight chained, branched, or cyclic C1-C20 hydrocarbon radical, which may be saturated, partially saturated, or aromatic, each of which may be optionally substituted with 1-6 heteroatoms selected from nitrogen, oxygen, sulfur, or halogen;
- RN is hydrogen or a saturated, partially saturated, or aromatic C1-C20 hydrocarbon radical, optionally substituted with 1-6 heteroatoms selected from nitrogen, oxygen, sulfur, or halogen;
- and cosmetically acceptable salts thereof.
- for a time sufficient to improve the aesthetic appearance of said human skin.
A method for improving the aesthetic appearance of human skin comprising topically applying to an area of the skin in need thereof a topical composition comprising a cosmetically acceptable vehicle and an effective amount of a compound having the structure of Formula I(b):
- and cosmetically acceptable salts thereof, for a time sufficient to improve the aesthetic appearance of said human skin.
A method for enhancing the production of collagen in human skin comprising topically applying to an area of the skin in need thereof a topical composition comprising a cosmetically acceptable vehicle, and an effective amount of a compound having the structure of Formula I(b):
- and cosmetically acceptable salts thereof.
A method for enhancing the production of collagen in human skin comprising topically applying to an area of the skin in need thereof a topical composition comprising a cosmetically acceptable vehicle, and an effective amount of a compound having the structure of Formula I(a):
- wherein,
- Q represents a 3-6 membered heterocyclic ring, wherein L1 and L2 are independently selected from a bond or a group ε1-(L3)l-ε2, where “l” is an integer from 0 to 4;
- where L3 is selected from —CH2—, —CHR*—, —C(R*)2—, —CH—, —CR*—, or a bond;
- and ε1 and ε2 are independently selected from —N—, —NH—, —NRN—, —O—, —S—, —(C═O)—, or a bond;
- Y is selected from —CH—, —CR*—, —CHR*—, —C(R*)2—, —N—, —O—, —S—, —NRN—, or a bond (i.e. absent);
- Z1 represents a bond, —CH2—, or —(C═O)—;
- Z2 represents a bond, —O—, NH—, —NRN—, —CH2—, —CHR*—, —C(R*)2—, —(CH2)p—, —(CH2)p—NH, or —(CH2)p—NRN—, where p is an integer from 1-6;
- X1 represents —CH2—, —CHR*—, —C(R*)2—, —NH—, —NRN—, —O—, or —S—;
- X2 and X3 represents nitrogen, —CH—, or —CR*—;
- R1-R5 are independently selected, at each occurrence, from a group R;
- wherein R is selected from hydrogen, —F;
- —Cl;
- —Br, —I;
- —OH, —OR*;
- —NH2;
- —NHR*;
- —N(R*)2;
- —N(R*)3+;
- —N(R*)—OH;
- —N(→O)(R*)2;
- —O—N(R*)2;
- —N(R*)—O—R*;
- —N(R*)—N(R*)2;
- —C═N—R*;
- —N═C(R*)2;
- —C═N—N(R*)2;
- —C(═NR*)—N(R*)2;
- —SH;
- —SR*;
- —CN;
- —NC;
- —(C═O)—R*;
- —CHO;
- —CO2H;
- —CO2−;
- —CO2R*;
- —(C═O)—S—R*;
- —O—(C═O)—H;
- —O—(C═O)—R*;
- —S—(C═O)—R*;
- —(C═O)—NH2;
- —(C═O)—N(R*)2;
- —(C═O)—NHNH2;
- —O—(C═O)—NHNH2;
- —(C═S)—NH2;
- —(C═S)—N(R*)2;
- —N(R*)—CHO;
- —N(R*)—(C═O)—R*;
- —(C═NR)—O—R*;
- —O—(C═NR*)—R*, —SCN;
- —NCS;
- —NSO;
- —SSR*;
- —N(R*)—C(═O)—N(R*)2;
- —N(R*)—C(═S)—N(R*)2;
- —SO2—R*;
- —O—S(═O)2—R*;
- —S(═O)2—OR*;
- —N(R*)—SO2—R*;
- —SO2—N(R*)2;
- —O—SO3−;
- —O—S(═O)2—OR*;
- —O—S(═O)—OR*;
- —O—S(═O)—R*;
- —S(═O)—OR*;
- —S(═O)—R*;
- —NO;
- —NO2;
- —NO3;
- —O—NO;
- —O—NO2;
- —N3;
- —N2—R*;
- —N(C2H4);
- —Si(R*)3;
- —CF3;
- —O—CF3;
- —PR*2;
- —O—P(═O)(OR*)2;
- —P(═O)(OR*)2;
- perfluoroalkyl;
- an aliphatic C1-C12 hydrocarbon radical;
- a C1-C12 aromatic hydrocarbon radical;
- or a C1-C12 heteroaryl radical;
- where R* is independently at each occurrence hydrogen or a straight chained, branched, or cyclic C1-C20 hydrocarbon radical, which may be saturated, partially saturated, or aromatic, each of which may be optionally substituted with 1-6 heteroatoms selected from nitrogen, oxygen, sulfur, or halogen;
- RN is hydrogen or a saturated, partially saturated, or aromatic C1-C20 hydrocarbon radical, optionally substituted with 1-6 heteroatoms selected from nitrogen, oxygen, sulfur, or halogen;
- and cosmetically acceptable salts thereof.
Dependencies are inferred from the claim text.